Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

The rapid rise of artificial intelligence (AI) has helped cardiologists, radiologists, nurses and other healthcare providers embrace precision medicine in a way that ensures more heart patients are receiving personalized care.

Diabetes increases risk of death, complications when patients undergo CABG or PCI for left main disease

Researchers also found that CABG and PCI were each associated with their own advantages and disadvantages, highlighting the importance of shared decision-making. 

March 15, 2024
too much niacin, also known as vitamin b3, may increase the risk of adverse cardiovascular events such as heart attacks and strokes.

Too much niacin? Excess vitamin B3 may increase risk of heart attack, stroke

Nutritionists view niacin, also known as vitamin B3, as a fundamental part of any diet. Consuming too much, however, could potentially be bad for the heart. 

March 15, 2024
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.

Cognitive impairment among heart failure patients: How cardiologists can help

The Heart Failure Society of America shared a new scientific statement about this topic, noting that many patients may require additional help.

March 13, 2024
Adults who regularly drink sweetened beverages face a heightened risk of atrial fibrillation (AFib), according to new data published in Circulation: Arrhythmia and Electrophysiology.

Heart issues more common in adults who drink soda, other sweetened beverages

Diet sodas made with artificial sweeteners are associated with an even higher risk of issues than sugar-sweetened sodas.

March 12, 2024
Weekly doses of semaglutide, a GLP-1 receptor originally developed to treat diabetes, could help approximately 93 million U.S. adults lose weight and reduce their risk of adverse cardiovascular events, according to new research published in Cardiovascular Drugs and Therapy. Novo Nordisk sells and markets subcutaneous treatments of semaglutide 2.4 mg under the brand name Wegovy.

A big win for Wegovy: Weight loss drug semaglutide first in history to gain FDA approval for reducing heart risks

The FDA made a special announcement about its decision, describing the news as "a major advance for public health."

March 8, 2024
Dexcom, a global healthcare technology company based out of San Diego, has received the first over-the-counter U.S. Food and Drug Administration (FDA) clearance for a wearable glucose biosensor that can be obtained without a prescription, the Stelo..

FDA clears first over-the-counter wearable device for continuous glucose monitoring

The newly cleared device is worn on the back of the arm and sends data directly to the user's smartphone. 

March 6, 2024

Ultra-processed foods linked to 32 adverse health outcomes, including CVD-related death and diabetes

Data from nearly 9.9 million participants were included in the team’s final analysis. The group emphasized the important role governments can play in trying to reverse the world's reliance on these products. 

March 4, 2024
Marijuana use among older adults is associated with a heightened risk of atrial and ventricular arrhythmias, according to new research published in the American Journal of Cardiology. “Marijuana use increases sympathetic nervous system activity and inhibits cardiac parasympathetic innervation, resulting in elevated heart rate, elevated blood pressure, and an increase in myocardial oxygen demand.

‘Just like smoking tobacco’: Cannabis use increases stroke risk by 42%, heart attack risk by 25%

“It can be a challenging discussion to have with patients because there is evidence that cannabis has some therapeutic properties," one researcher said. "However, as suggested by this study, cannabis use also has significant cardiovascular risks.”  

March 4, 2024

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup